The Immune System – Webinars and Online Events

Using the example of tumor-associated macrophages (TAMs), this webinar takes a closer look at immune cells in the tumor microenvironment (TME), helping us to gain a better understanding of how specific subtypes and their reprogramming may influence therapy efficiency.

Antibodies are ideal therapeutic biomolecules due to their ability to bind to a variety of targets with high affinity and specificity. Innovations in hybridoma and phage display technologies have enabled drug developers to exploit the natural diversity in antibodies, leading to the wide use of monoclonal antibodies.

Cancer cells engage in intricate interactions with neighboring cancerous and stromal cells through direct cell-to-cell contact and paracrine signaling. Long-range communication with distant organ sites is facilitated by extracellular vesicles, as well as signaling molecules like cytokines, hormones and growth factors .

To support the development of mRNA-based therapies scientists require platforms that will help to address the selectivity and capacity requirements for the large-scale manufacturing of mRNA used in vaccine and gene therapy applications.

Transmembrane proteins (TPs) in their full-length and biologically active form presents challenges in purification primarily due to their innate complex structures. To overcome the challenges of expressing TPs, the FLAG technology from Acrobio addresses their protein expression knowledge to provide highly bioactive, stabilized, native full-length multi-pass transmembrane target antigens for the development of immune-related targeted therapeutics.

Speaking at Cell & Gene Therapy 2023,Tracy Zhao from ACROBiosystems, presented their talk on products and services across cell therapy research and development.

This webinar explores how the latest humanized mouse models are advancing inflammatory disease research by helping scientists evaluate drug candidates of interest.

This webinar explores how the latest humanized mouse models are advancing immuno-oncology by helping researchers study immune checkpoint blockades.

Speaking at Cell and Gene Therapy 2023, Habib Malik from Bio-Techne, presented their talk on reproducible and easy-to-use immunoassay platforms.

The biopharma industry has used capillary electrophoresis for many years to help improve the quality of biopharmaceuticals. Traditionally, scientists have utilized single capillaries or chips in these systems, requiring samples to be run in series.
However, a new multi-capillary system was recently launched, enabling scientists to parallel process eight samples simultaneously. Discover the impact of multi-capillary systems in the development of cell and gene therapies and therapeutic proteins.